ALBERTINE JOHN M 4
Research Summary
AI-generated summary
TecoGen (TGEN) Director John M. Albertine Receives 25,000-Share Award
What Happened
John M. Albertine, a director of TecoGen Inc. (TGEN), was granted 25,000 shares as an award/acquisition on June 26, 2026. The filing lists an acquisition price of $5.17 per share, giving a total value of $129,250. This was an award/derivative grant (not an open‑market purchase or sale).
Key Details
- Transaction date: 2026-06-26
- Transaction type: Award/Grant (derivative acquisition) — 25,000 shares at $5.17 per share; total value $129,250
- Vesting: Vests 25% per year (footnote) — implies a four-year vesting schedule before full ownership/transferability
- Shares owned after transaction: Not reported in the Form 4 filing
- Filing timeliness: No late filing indicator reported
Context
This was a derivative award subject to a multi-year vesting schedule, meaning the shares are not fully vested or immediately tradable. Awards like this are routine for directors and compensate service; they are recorded as acquisitions on Form 4 but do not necessarily reflect immediate market activity.